|
MechanismmGluR4 positive allosteric modulators |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with IBDM
0 Patents (Medical) associated with IBDM
100 Deals associated with IBDM
100 Translational Medicine associated with IBDM